drug protocol number

CRAD001N2301

drug sponsor

Novartis

drug study

Everolimus

drug trial site

King Fahad Specialist Hospital (Dammam), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)

drug status

Completed

drug phase